Quest Diagnostics Forecasts 2024 Adjusted EPS Of $8.80-$9.00 Versus Prior Guidance Of $8.72-$8.97 And Consensus Of $8.86
Portfolio Pulse from Benzinga Newsdesk
Quest Diagnostics has updated its 2024 adjusted EPS forecast to a range of $8.80-$9.00, which is an increase from its prior guidance of $8.72-$8.97 and is above the consensus estimate of $8.86.
July 23, 2024 | 10:59 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Quest Diagnostics has raised its 2024 adjusted EPS forecast to $8.80-$9.00, which is higher than both its previous guidance and the consensus estimate. This positive revision is likely to boost investor confidence and could lead to a short-term increase in the stock price.
The upward revision in EPS guidance indicates stronger-than-expected financial performance, which is likely to positively influence investor sentiment and drive the stock price higher in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100